Entering a new era of molecular classification of brain tumors: An update of 2021 World Health Organization classification in adult gliomas-Reference-Cited by-全球学者库

Entering a new era of molecular classification of brain tumors: An update of 2021 World Health Organization classification in adult gliomas

Published:2023-02-06 Issue:2 Volume:56 Page:43-46
ISSN:1682-606X
Container-title:Formosan Journal of Surgery
language:en
Short-container-title:Formos J Surg

Author:

Wang Ching-Ying¹,Lin Shih-Chieh,Chen Ming-Teh,Lee Yi-Yen

Affiliation:

1. Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

Abstract

Abstract Glioma is the most common primary central nervous system tumor. The World Health Organization (WHO) 2021 classification of gliomas extended from WHO 2016 in the integration of molecular and histological classifications. WHO 2021 aims to establish a specific diagnosis that could reflect the biological and clinical features of the tumors, and further transform into more specific clinical studies or trials and therapeutics. Major updates of WHO 2021 classification focusing on glioma were reviewed in this article.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference22 articles.

1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2014–2018;Neuro Oncol,2021

2. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas;Cancer,1997

3. The 2016 World Health Organization classification of tumors of the central nervous system: a summary;Acta Neuropathol,2016

4. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;N Engl J Med,2015

5. IDH1 and IDH2 mutations in gliomas;N Engl J Med,2009